A little while back I referred to an item of consumer news I'd seen on the TV regarding the packaging of painkillers. It reported that some branded painkillers were labelled to indicate that they were particularly good for certain types of pain - e.g. "back pain", "period pain", "migraine", etc. - even though their licence numbers indicated that all of them had exactly the same constituents.
I was of the view that, because the drug companies were charging different prices for exactly the same product, this was unethical, if not illegal and that this was yet another example of the "unacceptable face of capitalism".
I recall at least one poster disagreeing and saying it was a case of "buyer beware" (or something to that effect) and that it was up to consumers to do check the ingredients and the licence number.
The I reported on 15th December that courts in Australia have found the drug company which produces Nurofen guilty of misleading customers by labelling the same products differently and using that implied different to charge significantly more. In Australia these products have been ordered to be removed from the shelves. This is apparently not the first time this company has used underhand methods. It had previously been fined £10.2 million by the Office of Fair Trading in this country for anti-competitive behaviour.
Now it is reported that an investigation will take place here as to labelling. It's a shame that our own consumer authorities had to be chivvied along by an Australian decision before taking investigative action but I'm hoping that the same decision will be reached here as in Australia.
How to Keep Living at Home Longer
How many tablets do you take in the morning?
Last letters become first - March 26




.